HDAC9 and acute myeloid leukemia: The upregulation of TAA expression resulted in an increased induction of tumor-specific cytotoxic T-lymphocytes (CTLs) in 15 MDS and AML patients treated with AZA and the HDAC-inhibitor valproate sodium [86].